As we previously published, a multiweapon approach is needed to successfully combat SARS-CoV-2 and COVID-19 disease (Labarrere and Kassab, 2021), involving vaccines (Jin et al., 2022) especially vaccines that selectively and efficiently induce antibodies that target the SARS-CoV-2 receptor binding domain (Robbiani et al., 2020), pattern recognition proteins such as surfactant proteins A and D (Arroyo et al., 2021
Ingredients such as berberine and chromium can affect glucose regulation, potentially interacting with certain medications
This is the concept of bioavailability
PMID: 28698222
Letting the vial sit at room temperature for two to three minutes before drawing can make the process slightly easier because cold solutions are more viscous
Yes, switching from a sulfonylurea to an incretin mimetic is possible and may be recommended if weight gain is problematic, particularly if your BMI is 35 kg/m or weight-related comorbidities are present